Delivered-To: tjphuhs@gmail.com
Received: by 2002:a05:6000:298f:20b0:451:8158:aa77 with SMTP id gl15-n2csp50175wrb;
        Tue, 5 May 2026 15:03:45 -0700 (PDT)
X-Received: by 2002:a05:622a:1e14:b0:50e:6313:6e12 with SMTP id d75a77b69052e-51461bfe0d6mr16037511cf.16.1778018625409;
        Tue, 05 May 2026 15:03:45 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1778018625; cv=none;
        d=google.com; s=arc-20240605;
        b=VaO9P6MSAeTI4FoINUsqfXisXO0WYG3n+nlKnV5OIrXEVyIkpuGKx7mmlROFAr9Eeb
         zlzYGlc2B+8IJnk4wX0x8uZnyDX7ehFex/2mM13BWdIhAhDU9V07Rc/d7hffozrp4ziK
         6t89RUq7j4z01/bYm+KK8nli7HtrEvZB5coKne9I6Kdl0OneGOVjDxribcgsSyFQ/ykd
         he7Y3uF1I5Gx5a1sb0Ads/PCEwUC6b9Kvr4vJRTroeG6zvK4HUUZLr5Mf0QWYLxGvImJ
         VGHSdjNH6JLrWlpPUa8mHUz4dGbImZaZwg12A6TXt1qAXjb/cF3sdNH3b2GiLUDgbTvS
         xzzQ==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605;
        h=message-id:date:mime-version:sid:subject:reply-to
         :list-unsubscribe-post:list-unsubscribe:from:feedback-id:to
         :dkim-signature:dkim-signature;
        bh=68eoxpMy4A/+6hhrqezpjJdjeSBXANBrEARLWrW7zQo=;
        fh=Hcu5VqhndQNvtVhwbc8tr7JrSOSQJms/+lG2L+E9gBs=;
        b=gdNkpF6PgIgJf+KixeLwGrasW6qXXMODajBnyaGjXje4QOEqxPybYibXNuc6KNQJ9y
         FyeUAG2kY00OTV+/zqr8AsuL3w7xl3IdvGHc5sn7GDUnKSXbYc7HF3AF8vnKb+RM3Y/7
         ev08NXGBkYujj0g/IiZVzrj+vY0fsP2T2QgEq2/uNoSfubCS3PzTZBywfG2P+KQni4n8
         T0oh+PW/rWheFPBzC58vb4R1xo4B4fPS629f5fUYITuRgQic2LvDnGBkIDf8kwSZQ6Cq
         /T4Lsaa22cSDoqCM5pfP6Xk/SKDJDkGpSCRZW1Ce4ydSqmNccCIPLndRmZsCrMDvtKuT
         utiA==;
        dara=google.com
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b=GbXcMfS0;
       dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=Yd1f64CQ;
       spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.32 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com";
       dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com
Return-Path: <bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com>
Received: from bh186-32.smtp-out.beehiivmail.net (bh186-32.smtp-out.beehiivmail.net. [69.67.186.32])
        by mx.google.com with ESMTPS id d75a77b69052e-51040b4276esi159730521cf.259.2026.05.05.15.03.45
        for <tjphuhs@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256);
        Tue, 05 May 2026 15:03:45 -0700 (PDT)
Received-SPF: pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.32 as permitted sender) client-ip=69.67.186.32;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@bhmta.beehiiv.com header.s=bh header.b=GbXcMfS0;
       dkim=pass header.i=@mail.beehiiv.com header.s=bh header.b=Yd1f64CQ;
       spf=pass (google.com: domain of bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com designates 69.67.186.32 as permitted sender) smtp.mailfrom="bounces+tjphuhs=gmail.com@bh.mail.beehiiv.com";
       dmarc=pass (p=REJECT sp=REJECT dis=NONE) header.from=beehiiv.com
X-BmtaRef: eyJfQF8iOiJcXF8vIiwicmVjaXBpZW50IjoidGpwaHVoc0BnbWFpbC5jb20iLCJ4X2xpc3RfaWQiOiJmZDQxNjMwZS1lOTFmLTQ2ZDktYTI3NC1iNzQwZGFiNzU2ZDIiLCJ4X3N1YnNjcmliZXJfaWQiOiI5YzQwZDYzOS02ZTFkLTQyOTItYTlkNy0wZTRjYmJiNWQ1ZGIifQ==
DKIM-Signature: v=1; a=rsa-sha256; d=bhmta.beehiiv.com; s=bh; c=relaxed/relaxed;
	bh=68eoxpMy4A/+6hhrqezpjJdjeSBXANBrEARLWrW7zQo=;
	h=from:subject:mime-version:content-type:content-transfer-encoding:
		list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc:
		content-type:feedback-id:from:subject:to; t=1778018625;
	b=GbXcMfS0SEuUaPz8sIUNycAZnSfU+IpsU482ol2Po3USkc2qgE0vnXJrjIwkUG8qryC53qtLO
	LjCeiZ+ybjZ/4+zxhPZ3eEKd2DJLW/K2ynI8tPFWwFnzjByBTl0P6YcVsMEc2/VFHG+TR25RXU6
	Da4auBzbcirYYuY/upM1SpwFAR9sXZiFy1x8nIWAKyeP3GhgMlkzNnO//P2SxSf+5SUfTuL3/vI
	LyndtMfDSMH+lgYJ/eekvZAFc/mG9iSFrg6LailaDfpYxdBDy6TuQYJ3VpgyNYd3sHakNlkVRO7
	fw9hx3jtMYZ/739DpN/6wItHu3Vryf18pNU3lObSs7WA==;
DKIM-Signature: v=1; a=rsa-sha256; d=mail.beehiiv.com; s=bh; c=relaxed/relaxed;
	bh=68eoxpMy4A/+6hhrqezpjJdjeSBXANBrEARLWrW7zQo=;
	h=from:subject:mime-version:content-type:content-transfer-encoding:
		list-unsubcribe:feedback-id:list-unsubscribe-post:reply-to:to:cc:
		content-type:feedback-id:from:subject:to; t=1778018625;
	b=Yd1f64CQt2rEBjYtLBle9bh4pekhBspzxnd/5LA9KB7qlVTkvlrxTChPuuKyBw0uzfEBrs5LA
	givToIYzrZxzOJR1XvQhYrUl4WQFbo7Ib4doSy6oOQsp2RaTEmhW1dNcOIUBo7OM3Qp4yxNN7ix
	k3HOOa7gPcUyZXFJR1VbghG9p1389ih/PkCx+7va46/SGq5jrkXDLeR7DnLYTslMjGL0UfD2wKM
	HxeQ/BRUjnZQ0QVhPbjMA3rCuq255px0XwLh5IDgBaYn6qUT6XKCxQNL1yY1es/RexL+JVfqRGs
	sIP3cSMvJFfxKq86UaaACFpcIyTy20jDJgfWE/So794A==;
Received: from mail.beehiiv.com by bhmta(mta16) with
    HTTP id <491b8e2348ce11f19d5f12457269f165> for <tjphuhs@gmail.com>;
    Tue, 05 May 2026 22:03:45 +0000
Content-Type: multipart/alternative;
	boundary="u4HWCmXeT+aYztS0dSW/Ug"
To: "tjphuhs@gmail.com" <tjphuhs@gmail.com>
Feedback-ID: 7d1ff928-ed92-4638-a57f-bca8468c72c6:newsletter:fd41630e-e91f-46d9-a274-b740dab756d2:c8f61fda6a60803
From: Hunter Williams <huntershealthhacks@mail.beehiiv.com>
List-Unsubscribe: <mailto:fd41630e-e91f-46d9-a274-b740dab756d2+9c40d639-6e1d-4292-a9d7-0e4cbbb5d5db+7d1ff928-ed92-4638-a57f-bca8468c72c6@unsub.beehiiv.com>,
	<https://huntershealthhacks.beehiiv.com/unsubscribe/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWJzY3JpYmVyX2lkIjoiOWM0MGQ2MzktNmUxZC00MjkyLWE5ZDctMGU0Y2JiYjVkNWRiIiwicG9zdF9pZCI6IjdkMWZmOTI4LWVkOTItNDYzOC1hNTdmLWJjYTg0NjhjNzJjNiIsImxhc3RfcmVzb3VyY2VfZ3VpZCI6IlBvc3Q6N2QxZmY5MjgtZWQ5Mi00NjM4LWE1N2YtYmNhODQ2OGM3MmM2In0.gW06NLF6WfWmQQcGu7csN4QxfnVIzQtN13mlfkYkDVs>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
Reply-To: =?utf-8?Q?Hunter=27s_Health_Hacks?= <hunter@zeroats.com>
Subject: Non-GLP Fat Loss Compounds Ranked
X-Batch-Id: 6e9d00b4-f044-4b76-94fe-a0d04b8c99d5
X-Subscriber-ID: 9c40d639-6e1d-4292-a9d7-0e4cbbb5d5db
X-Subscription-ID: 663283104
sId: fd41630e-e91f-46d9-a274-b740dab756d2
x-beehiiv-ids: {"account_name":"https://huntershealthhacks.beehiiv.com/","campaign_id":"7d1ff928-ed92-4638-a57f-bca8468c72c6","category":"newsletter","email_generated_at":1778018624,"user_id":"fd41630e-e91f-46d9-a274-b740dab756d2"}
x-beehiiv-type: newsletter
x-list-id: fd41630e-e91f-46d9-a274-b740dab756d2
x-list-owner: <mailto:hunter@zeroats.com>
x-newsletter: https://huntershealthhacks.beehiiv.com/p/non-glp-fat-loss-compounds-ranked
x-newsletter-id: https://huntershealthhacks.beehiiv.com/
x-newsletter-signup: https://huntershealthhacks.beehiiv.com/subscribe
Mime-Version: 1.0
Date: Tue, 5 May 2026 22:03:45 +0000
Message-ID: <20260505.220345.e39e48a5@mta16>

--u4HWCmXeT+aYztS0dSW/Ug
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Happy Tuesday! =0A=0AMost folks would agree that the GLPs are the kings of =
fat loss, with retatrutide holding the title belt.=0A=0ABut what if GLPs ar=
e not on the table for you? What if you are cycling off? What if you want t=
o stack other compounds so you don=E2=80=99t have to crank your GLP dose in=
to the stratosphere?=0A=0AI just dropped a brand-new video and podcast epis=
ode where I rank=C2=A0**20 non-GLP-1 fat-loss**** compounds** from F tier t=
o S tier. Most are peptides. A few are small molecules. All of them have a =
place in the conversation right now.=0A=0AYoutube: 20 Fat Loss Compounds Ra=
nked Worst to Best (No GLP-1s) (https://youtu.be/36E7xjuFVXc)=0A=0AYou can =
watch the full video here: [https://youtu.be/36E7xjuFVXc](https://youtu.be/=
36E7xjuFVXc)=0A=0AOr listen on Spotify here: [https://open.spotify.com/epis=
ode/3jOsxcgx8n4EaOhhaNCuCv?si=3DTIs_SV5eT6KTmarCWf7cZA](https://open.spotif=
y.com/episode/3jOsxcgx8n4EaOhhaNCuCv?si=3DTIs_SV5eT6KTmarCWf7cZA)=0A=0ABelo=
w is the breakdown of every compound and why I ranked it where I did.=0A=0A=
=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94=0A=0A_**F Tier (I Don't Use These)**_=0A=0A**Adipotide (=
FTPP).** This one targets fat cells by killing the blood vessels that feed =
them. Sounds elegant on paper. The problem is that the kidneys are damaged =
at the same doses that produce the fat loss. Phase 1 data in obese prostate=
 cancer patients showed real fat loss but also dose-dependent renal toxicit=
y. The risk-to-reward is not there for me. I am sure people are using it. I=
 just choose not to.=0A=0A**HGH Fragment 176-191.** This is not HGH. It is =
a fragment of the HGH amino acid sequence. The human data is weak. AOD9604 =
is essentially the same thing with an added tyrosine for stability, and eve=
n AOD isn=E2=80=99t great. If you are taking HGH frag, you are wasting your=
 money.=0A=0A_**D Tier (Weak Use Case)**_=0A=0A**AOD9604.** A 12-week phase=
 2 trial showed about 2 kg of fat loss compared with placebo. That is rough=
ly 4 to 5 pounds. Not nothing. But not exciting either when GLPs exist. I h=
ave used it. The one place it might earn its keep is helping with water ret=
ention from growth hormone or GH peptides. As a standalone fat loss tool, s=
kip it.=0A=0A_**C Tier (Use Case Exists, But Outclassed)**_=0A=0A**Sermorel=
in.** It is a GHRH peptide. It works. It is just the weakest of the GH pept=
ide family and has been outclassed by tesamorelin, CJC, and ipamorelin. If =
it is what you have, fine. If you are choosing fresh, pick something else.=
=0A=0A**Setmelanotide.** An MC4R agonist that absolutely will suppress your=
 appetite. The problem is the nausea. I took 250 micrograms and felt fine f=
or about 6 hours. Then the nausea hit and lasted a day or two. Take the wor=
st semaglutide nausea you have ever felt and crank it up. The FDA-approved =
dose is 2 to 3 mg daily, and I have no idea how anyone tolerates that. For =
people with specific genetic obesity syndromes, it can be life-changing. Fo=
r everyone else, it is a glutton-for-punishment compound.=0A=0A_**B Tier (S=
olid, Conditional Wins)**_=0A=0A**Tesofensine.** A triple monoamine reuptak=
e inhibitor. Phase 3 data in obese Mexican patients showed 8.6 kg of weight=
 loss vs 1.9 kg placebo over 24 weeks. I love this one for the cognitive li=
ft. It feels like a nootropic. About 70% of people do well on it. About 20%=
 do terribly with insomnia, anxiety, or feeling wired. I run 250 mcg and ge=
t great benefits. Watch your heart rate and blood pressure.=0A=0A**SS-31.**=
 Not a fat loss peptide on paper. But it repairs the mitochondrial hardware=
. Fix the mitochondria, and everything works better, including fat loss. I =
run 1 to 2 mg for general optimization and 5 to 10 mg for a real metabolic =
effect. It earns its place because it improves the rest of your stack.=0A=
=0A**Cagrilintide.** A long-acting amylin analog that suppresses appetite t=
hrough a completely different mechanism than GLPs. With semaglutide, it pro=
duced 20.4% weight loss over 68 weeks. On its own, around 10 to 11% at high=
er doses. I do great on it. My wife, Taylor, feels depressed and emotionall=
y blunted on it. About half the people I see using it report that. Coin fli=
p. Start at 250 mcg and titrate up.=0A=0A**IGF-1 LR3.** This is more of a b=
ody recomposition tool than a fat-loss tool. Run alongside HGH or a GH pept=
ide for 4 to 6 weeks at 25 to 200 mcg post-workout. Watch your blood sugar.=
 Always have carbs on hand. Hypoglycemia is the real risk.=0A=0A**Cardarine=
 (GW501516).** A PPAR agonist that shifts you toward fatty acid oxidation. =
By itself, it will not melt fat. Paired with cardio, you get way more out o=
f every session. I run 10 mg per day for 4 to 8 weeks. There is a cancer si=
gnal in mice (in both directions), which is why I keep doses moderate and c=
ycle.=0A=0A_**A Tier (Where Things Get Real)**_=0A=0A**CJC + Ipamorelin.** =
Not a fat loss peptide directly. But the downstream effects on sleep, IGF-1=
, and recovery move the needle on body composition. Most people tolerate ip=
amorelin well. CJC can give some folks reactions. Try them in isolation fir=
st before stacking. I would call this an A-minus.=0A=0A**MOTS-c.** A mitoch=
ondrial peptide that improves fatty acid oxidation, glucose uptake, and ins=
ulin sensitivity. Acts as an exercise mimetic. I run 1 to 2 mg subQ daily, =
5 days on, 2 days off, for 8 weeks on, 8 weeks off. At 1 milligram with 5-A=
mino, I felt like a 7-year-old being told to sit still. Solid A or A+.=0A=
=0A**5-Amino-1MQ.** An NNMT inhibitor that raises intracellular NAD+ and ma=
kes fat cells resistant to lipolysis blockade. Mouse studies show a 30 to 4=
0% reduction in fat cell size with no change in food intake. Injectable wor=
ks much better than oral. I run 1 to 2 mg injected daily. Push past 2 milli=
grams, and you start to feel burnout. With MOTS-c, I would call the combo a=
n A+.=0A=0A**BAM15.** A mitochondrial uncoupler. Your cell burns more fuel =
to maintain ATP, and the energy gets dumped as heat. Wider therapeutic wind=
ow than DNP. Strong rodent data, no human safety pharmacology yet. I run 50=
 to 100 mg a day. Above 400 mg, there are diminishing returns.=0A=0A**SLU-P=
P-332.** An estrogen-related receptor agonist that drives mitochondrial bio=
genesis and fatty acid oxidation. The most studied exercise mimetic in this=
 class. I prefer 250-750 mcg daily for 8-12 weeks. Higher doses just made m=
e feel worse. Oral works fine. Transdermal works great. Injectable in oil m=
ight be the best delivery method, but the data isn't clean enough yet to ca=
ll it.=0A=0A**ATX-304.** A pan-AMPK activator that does not cross the blood=
-brain barrier. Real human data, no appetite suppression, no muscle loss. T=
rials used 1,000 milligrams, which is cost-prohibitive for most. I get grea=
t results at 300-500 mg daily. Energy is solid, fat loss is real, and water=
 retention drops. A+.=0A=0A**Mirabegron.** A beta-3 adrenergic agonist. Act=
ivates brown fat thermogenesis and improves insulin sensitivity. FDA-approv=
ed for overactive bladder. For body comp, 50-100 mg a day. Great for the la=
st few weeks of a cut. Watch your heart rate, blood pressure, and urinary r=
etention at higher doses.=0A=0A_**S Tier (The Best We Have)**_=0A=0A**Albut=
erol.** A beta-2 agonist that activates lipolysis through hormone-sensitive=
 lipase. Increases resting energy expenditure 3 to 5%. FDA-approved since 1=
981 with decades of safety data. I run 2 to 5 mg orally per day, 2 weeks on=
 2 weeks off. The receptors downregulate after about 2 to 3 weeks, which is=
 why you cycle. The only reason I call it S-minus is that short cycle windo=
w. =0A=0A**HGH.** The most underrated fat loss tool we have. Direct GH rece=
ptor activation. Increased fatty acid oxidation. Reduced glucose uptake in =
fat tissue. Decades of human data. In GH-deficient adults, 4 to 7 kg fat re=
duction and 2 to 5 kg lean mass increase over 6 to 12 months. Most men in t=
heir 40s, 50s, and 60s probably qualify as deficient. Run 1 to 4 IU daily. =
It is not a 2-week shred tool. Over 1 to 2 years, the body just transforms.=
=0A=0A**Tesamorelin.** S-tier-plus from a data standpoint. A GHRH that stim=
ulates pulsatile pituitary GH release. Phase 3 data in HIV lipodystrophy pa=
tients showed about 15% reduction in visceral fat over 6 months, with lean =
mass preserved or increased. The only non-GLP-1 fat loss peptide with phase=
 3 human data and FDA approval. 1 to 2 mg subQ daily, 5 days on 2 days off,=
 8 to 16 weeks on, 4 to 8 weeks off. If you are already lean and chasing si=
ngle-digit body fat, the water retention may mask the changes. If you are 2=
5%+ body fat trying to drop into the teens, this works incredibly well.=0A=
=0A=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=
=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=
=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=94=E2=80=
=94=E2=80=94=E2=80=94=0A=0A**Final Thoughts**=0A=0AEvery compound on this l=
ist has a place. Even the F-tier ones have a use case for somebody, just no=
t for me.=0A=0AThe mistake people make is reaching for one tool and crankin=
g the dose until something gives. With everything on this list, you can rot=
ate through different mechanisms. =0A=0AAMPK one cycle. Mitochondrial uncou=
pling the next. Brown fat thermogenesis the cycle after that. Each pathway =
hits differently. Each cycle gives the others a chance to reset.=0A=0AHormo=
nes first. Lifestyle second. Compounds third. That order does not change.=
=0A=0AAlso, remember this is just my opinion. There are great compounds I l=
eft off this list. There are people smarter than me who would rank some of =
these differently. I would actually love to hear it. If you think I got som=
ething wrong, drop it in the YouTube or Spotify comments. The conversation =
is what moves the field forward.=0A=0AIf you want my full reasoning on each=
 compound, the dosing protocols, and the reactions I have personally seen, =
watch the video or listen to the episode. I cover way more than I could fit=
 in here.=0A=0AAs always, thank you for being here. I have the best audienc=
e in the world! =0A=0ABest,=0A=0AHunter Williams=0A=0A=0A=E2=80=94=E2=80=94=
=E2=80=94=0A=0AYou are reading a plain text version of this post. For the b=
est experience, copy and paste this link in your browser to view the post o=
nline:=0Ahttps://huntershealthhacks.beehiiv.com/p/non-glp-fat-loss-compound=
s-ranked
--u4HWCmXeT+aYztS0dSW/Ug
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html><html lang=3D"en" xmlns=3D"http://www.w3.org/1999/xhtml" xml=
ns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-microsoft-com=
:office:office" style=3D"font-size:16px;"><head></head><head><meta charset=
=3D"utf-8"/><!--[if !mso]><!--><meta http-equiv=3D"X-UA-Compatible" content=
=3D"IE=3Dedge"/><!--<![endif]--><meta name=3D"viewport" content=3D"width=3D=
device-width,initial-scale=3D1"/><meta name=3D"x-apple-disable-message-refo=
rmatting"/><meta name=3D"format-detection" content=3D"telephone=3Dno,addres=
s=3Dno,email=3Dno,date=3Dno,url=3Dno"/><meta name=3D"color-scheme" content=
=3D"light"/><meta name=3D"supported-color-schemes" content=3D"light"/><titl=
e>Non-GLP Fat Loss Compounds Ranked</title><!--[if mso]><xml><o:OfficeDocum=
entSettings><o:AllowPNG/><o:PixelsPerInch>96</o:PixelsPerInch></o:OfficeDoc=
umentSettings></xml><![endif]--><style>=0A  :root { color-scheme: light; su=
pported-color-schemes: light; }=0A  body { margin: 0; padding: 0; min-width=
: 100%!important; -ms-text-size-adjust: 100% !important; -webkit-transform:=
 scale(1) !important; -webkit-text-size-adjust: 100% !important; -webkit-fo=
nt-smoothing: antialiased !important; }=0A  .body { word-wrap: normal; word=
-spacing:normal; }=0A  table.mso { width: 100%; border-collapse: collapse; =
padding: 0; table-layout: fixed; }=0A  img { border: 0; outline: none; }=0A=
  table {  mso-table-lspace: 0px; mso-table-rspace: 0px; }=0A  td, a, span =
{  mso-line-height-rule: exactly; }=0A  #root [x-apple-data-detectors=3Dtru=
e],=0A  a[x-apple-data-detectors=3Dtrue],=0A  #MessageViewBody a { color: i=
nherit !important; text-decoration: inherit !important; font-size: inherit =
!important; font-family: inherit !important; font-weight: inherit !importan=
t; line-height: inherit !important; }=0A  span.MsoHyperlink { color: inheri=
t !important; mso-style-priority: 99 !important; }=0A  span.MsoHyperlinkFol=
lowed { color: inherit !important; mso-style-priority: 99 !important; }=0A =
 .a { background-color:#FFFFFF; }=0A  .b { background-color:#FFFFFF; }=0A  =
.c  { background-color:#FFFFFF; }=0A  .d { background-color:#EAEBEC; }=0A  =
.d2 { background-color:#FFFFFF; }=0A  .d3 { background-color:#FFFFFF; }=0A =
 h1 a { text-decoration:underline;color:#0C4A6E !important;font-style:itali=
c; }=0A  h2 a { text-decoration:underline;color:#0C4A6E !important;font-sty=
le:italic; }=0A  h3 a { text-decoration:underline;color:#0C4A6E !important;=
font-style:italic; }=0A  h4 a { text-decoration:underline;color:#0C4A6E !im=
portant;font-style:italic; }=0A  h5 a { text-decoration:underline;color:#0C=
4A6E !important;font-style:italic; }=0A  h6 a { text-decoration:underline;c=
olor:#0C4A6E !important;font-style:italic; }=0A  h1, h1 a, h2, h2 a, h3, h3=
 a, h4, h4 a, h5, h5 a, h6, h6 a, ul, li, ol, p, p a { margin: 0;padding: 0=
; }=0A  h1 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;f=
ont-weight:400;font-size:28px;color:#2A2A2A;line-height:1.75;padding-bottom=
:4px;padding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }=
=0A  h2 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font=
-weight:400;font-size:24px;color:#2A2A2A;line-height:1.5;padding-bottom:4px=
;padding-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }=0A  h=
3 { font-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-weigh=
t:400;font-size:20px;color:#2A2A2A;line-height:1.25;padding-bottom:4px;padd=
ing-top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }=0A  h4 { f=
ont-family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-weight:400=
;font-size:18px;color:#2A2A2A;line-height:1.125;padding-bottom:4px;padding-=
top:16px;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }=0A  h5 { font-=
family:'Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-weight:400;fon=
t-size:16px;color:#2A2A2A;line-height:1;padding-bottom:4px;padding-top:16px=
;mso-margin-top-alt:16px;mso-margin-bottom-alt:4px }=0A  h6 { font-family:'=
Trebuchet MS','Lucida Grande',Tahoma,sans-serif;font-weight:400;font-size:1=
4px;color:#2A2A2A;line-height:0.875;padding-bottom:4px;padding-top:16px;mso=
-margin-top-alt:16px;mso-margin-bottom-alt:4px }=0A  p { font-family:'Helve=
tica',Arial,sans-serif;font-weight:400;color:#2D2D2D;font-size:16px;line-he=
ight:1.5;padding-bottom:12px;padding-top:12px;mso-margin-top-alt:12px;mso-m=
argin-bottom-alt:12px; }=0A  p a, .e a, ul a, li a, .h a, .h2 a, .h3 a { wo=
rd-break:break-word;color:#0C4A6E !important;text-decoration:underline;text=
-decoration-color:#0C4A6E;font-style:italic; }=0A  p a span, .e a span, ul =
a span, li a span { color: inherit }=0A  p .bold { font-weight:bold;color:#=
2D2D2D; }=0A  p span[style*=3D"font-size"] { line-height: 1.6; }=0A  .f p {=
 font-size:12px;line-height:15px;color:#2D2D2D;padding:0; }=0A  .f p a { co=
lor:#2D2D2D !important; }=0A  .g p { font-family:'Helvetica',Arial,sans-ser=
if;font-size:14px;line-height:20px;font-weight:normal;margin:0; }=0A  .g p =
a  { text-decoration: underline; }=0A  .i p { font-family:'Helvetica',Arial=
,sans-serif;line-height:1.5;font-size:15px;color:#2D2D2D; }=0A  .i p a { co=
lor:#2D2D2D !important; }=0A  .i2 p { font-family:'Helvetica',Arial,sans-se=
rif;line-height:1.5;font-size:15px;color:#2D2D2D; }=0A  .i2 p a { color:#2D=
2D2D !important; }=0A  .i3 p { font-family:'Helvetica',Arial,sans-serif;lin=
e-height:1.8;font-size:24px;color:#2D2D2D; }=0A  .i3 p a { color:#2D2D2D !i=
mportant; }=0A  .h p a { color:#0C4A6E !important; }=0A  .h2 p a { color:#0=
C4A6E !important; }=0A  .h3 p a { color:#0C4A6E !important; }=0A  .f p a, .=
i p a, .i2 p a, .i3 p a, .h p a, .h2 p a, .h3 p a { text-decoration:underli=
ne; }=0A  .j { border-top:3px solid #030712; }=0A  .k p { padding-left:15px=
;padding-bottom:0px;padding-top:6px;mso-margin-top-alt:6px;mso-margin-botto=
m-alt:0px;mso-margin-left-alt:15px; }=0A  .o { background-color:#FFFFFF;bor=
der:1px solid #F1F1F1;border-radius:5px; }=0A  .o p { font-family:'Helvetic=
a',Arial,sans-serif;padding:0px;margin:0px; }=0A  .l p,=0A  .l p a, .l a { =
font-size:14px;line-height:20px;font-weight: bold;color:#2D2D2D;padding-bot=
tom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }=0A  .m p,=0A  .m =
p a { font-size:13px;line-height:18px;font-weight:400;color:#2D2D2D;padding=
-bottom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }=0A  .n p,=0A =
 .n p a { font-size:12px;line-height:17px;font-weight:400;color:#2D2D2D;pad=
ding-bottom:6px;mso-margin-bottom-alt:6px;text-decoration:none; }=0A  .p { =
background-color:#FFFFFF;max-width:520px;border:1px solid #E1E8ED;border:1p=
x solid rgba(80, 80, 80, 0.3);border-radius:5px; }=0A  .q { font-size:16px;=
font-family:Helvetica,Roboto,Calibri,sans-serif !important;border:1px solid=
 #e1e8ed;border:1px solid rgba(80, 80, 80, 0.3);border-radius:10px;backgrou=
nd-color:#FFFFFF; }=0A  .q p { font-size:16px;font-family:system-ui,Helveti=
ca,Roboto,Calibri,sans-serif !important;color:#222222;padding:4px 0; }=0A  =
.r { border:1px solid #E1E8ED !important;border-radius:5px; }=0A  .s p { fo=
nt-size: 14px; line-height: 17px; font-weight: 400; color: #697882; text-de=
coration: none; }=0A  .t p { font-family:'Helvetica',Arial,sans-serif;font-=
size:12px;line-height:1.5;font-weight:400;color:#000000;font-style:italic;p=
adding:0px; }=0A  .v { border-radius:10px;border:solid 0px #030712;backgrou=
nd-color:#030712;font-family:'Verdana',Geneva,sans-serif;color:#FFFFFF; }=
=0A  .v a { text-decoration:none;display:block;color:#FFFFFF; }=0A  .w p { =
font-size:12px;line-height:15px;font-weight:400;color:#2D2D2D; }=0A  .w p a=
 { text-decoration: underline !important;color:#2D2D2D !important; }=0A  ul=
 { font-family:'Helvetica',Arial,sans-serif;margin:0px 0px 0px 25px !import=
ant;padding:0px !important;color:#2D2D2D;line-height:24px;list-style-type:d=
isc !important;font-size:16px; }=0A  ul ul { list-style-type:circle !import=
ant; }=0A  ul ul ul { list-style-type:square !important; }=0A  ul ul ul ul =
{ list-style-type:disc !important; }=0A  ul ul ul ul ul { list-style-type:c=
ircle !important; }=0A  ul ul ul ul ul ul { list-style-type:square !importa=
nt; }=0A  ul ul ul ul ul ul ul { list-style-type:disc !important; }=0A  ul =
ul ul ul ul ul ul ul { list-style-type:circle !important; }=0A  ul ul ul ul=
 ul ul ul ul ul { list-style-type:square !important; }=0A  ul > li { font-f=
amily:'Helvetica',Arial,sans-serif;margin:10px 0px 0px 0px !important;paddi=
ng: 0px 0px 0px 0px !important; color: #2D2D2D; }=0A  .poll-choices > li { =
margin: 4px 0px 0px 0px !important; }=0A  ol { font-family:'Helvetica',Aria=
l,sans-serif;margin: 0px 0px 0px 25px !important;padding:0px !important;col=
or:#2D2D2D;line-height:24px;list-style:decimal;font-size:16px; }=0A  ol > l=
i { font-family:'Helvetica',Arial,sans-serif;margin:10px 0px 0px 0px !impor=
tant;padding: 0px 0px 0px 0px !important; color: #2D2D2D; }=0A  li > p, li =
p { font-family:'Helvetica',Arial,sans-serif;font-size:16px;font-weight:nor=
mal;line-height:24px;padding:0px; }=0A  .e h3,=0A  .e p,=0A  .e span { padd=
ing-bottom:0px;padding-top:0px;mso-margin-top-alt:0px;mso-margin-bottom-alt=
:0px; }=0A  .e span,=0A  .e li { font-family:'Helvetica',Arial,sans-serif;f=
ont-size:16px;color:#2D2D2D;line-height:24px; }=0A  .rec { font-family:  ui=
-sans-serif, system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", Robo=
to, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", =
"Segoe UI Emoji", "Segoe UI Symbol", "Noto Color Emoji" !important; }=0A  .=
rec__button:hover { background-color: #f9fafb !important; }=0A  .copyright =
a {color: inherit !important; text-decoration: none !important; font-size: =
inherit !important; font-family: inherit !important; font-weight: inherit !=
important; line-height: inherit !important;}=0A  .txt_social p { padding: 0=
; word-break: break-all; }=0A  .table, .table-c, .table-h { border: 1px sol=
id #C0C0C0; }=0A  .table-c { padding:5px; background-color:#FFFFFF; }=0A  .=
table-c p { color: #2D2D2D; font-family:'Helvetica',Arial,sans-serif !impor=
tant;overflow-wrap: break-word; }=0A  .table-h { padding:5px; background-co=
lor:#F1F1F1; }=0A  .table-h p { color: #2A2A2A; font-family:'Trebuchet MS',=
'Lucida Grande',Tahoma,sans-serif !important;overflow-wrap: break-word; }=
=0A  @media only screen and (max-width:667px) {=0A    .aa, .w100pc { width:=
 100% !important; }=0A    .bb img { width: 100% !important; height: auto !i=
mportant; max-width: none !important; }=0A    .cc { padding: 0px 8px !impor=
tant; }=0A    .ee { padding-top:10px !important;padding-bottom:10px !import=
ant; }=0A    .ff ul, .ff ol { margin: 0px 0px 0px 10px !important;padding: =
0px !important; }=0A    .ff li { margin:10px 0px 0px 10px !important; }=0A =
   .r {height:140px !important;}=0A    .s p { font-size:13px !important;lin=
e-height:15px !important; }=0A    .mob-hide {display:none !important;}=0A  =
  .mob-show {display: block !important; width: auto !important; overflow: v=
isible !important; float: none !important; max-height: inherit !important; =
line-height: inherit !important;}=0A    .mob-stack {width:100% !important;d=
isplay:block !important;}=0A    .mob-w-full {width:100% !important;}=0A    =
.mob-block {display:block !important;}=0A    .embed-img {padding:0px 0px 12=
px 0px !important;}=0A    .socialShare {padding-top:15px !important;}=0A   =
 .rec { padding-left:15px!important;padding-right:15px!important; }=0A    .=
bodyWrapper { padding:10px 4px 10px 4px !important; }=0A    .social-mobile =
{float:left !important;margin-top:10px !important;}=0A  }=0A  @media screen=
 and (max-width: 480px) {=0A    u + .a .gg { width: 100% !important; width:=
 100vw !important; }=0A    .tok-heart { padding-top:75% !important; }=0A   =
 .tok-play { padding-top: 250px !important; }=0A  }=0A  @media screen and (=
max-width: 320px) {=0A    .tok-heart { padding-top:65% !important; }=0A  }=
=0A  .u { border: 1px solid #CACACA !important; border-radius: 2px !importa=
nt; background-color: #ffffff !important; padding: 0px 13px 0px 13px !impor=
tant; font-family:ui-sans-serif,system-ui,-apple-system,BlinkMacSystemFont,=
"Segoe UI",Roboto,"Helvetica Neue",Arial,"Noto Sans",sans-serif !important;=
font-size: 12px !important; color: #767676 !important; }=0A  .u a { text-de=
coration: none; display: block !important; color: #767676 !important; margi=
n: 0px !important; }=0A  .u span, .u img { color: #767676 !important;margin=
:0px !important; max-height:32px !important;background-color:#ffffff !impor=
tant; }=0A</style><!--[if mso]><style type=3D"text/css">=0A    h1, h2, h3, =
h4, h5, h6 {font-family: Arial, sans-serif !important;}=0A    body, table, =
td, p, a, span {font-family: Arial, sans-serif !important;}=0A    sup { fon=
t-size: 100% !important;vertical-align: .5em !important;mso-text-raise: -1.=
5% !important;line-height: 0 !important; }=0A    ul { margin-left:0px !impo=
rtant; margin-right:10px !important; margin-top:20px !important; margin-bot=
tom:20px !important; }=0A    ul li { margin-left: 0px !important; mso-speci=
al-format: decimal; }=0A    ol { margin-left:0px !important; margin-right:1=
0px !important; margin-top:20px !important; margin-bottom:20px !important; =
}=0A    ol li { margin-left: 0px !important; mso-special-format: decimal; }=
=0A    li.listItem { margin-left:15px !important; margin-top:0px !important=
; }=0A    .paddingDesktop { padding: 10px 0 !important; }=0A    .edm_outloo=
klist { margin-left: -20px !important; }=0A    .embedImage { display:none !=
important; }=0A</style><![endif]--><!-- 9c40d639-6e1d-4292-a9d7-0e4cbbb5d5d=
b --><style></style></head><body class=3D"a" style=3D"margin:0px auto;paddi=
ng:0px;word-wrap:normal;word-spacing:normal;background-color:#FFFFFF;"><div=
 role=3D"article" aria-roledescription=3D"email" aria-label=3D"email_name" =
lang=3D"en" style=3D"font-size:1rem"><div style=3D"display:none;max-height:=
0px;overflow:hidden;"> New Video is Live! &#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#820=
4;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#=
8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160=
;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#=
160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204=
;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;=
&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#1=
60;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;=
&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#82=
04;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#820=
4;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#=
8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160=
;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#=
160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204=
;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;=
&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#1=
60;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;=
&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#82=
04;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&=
#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#16=
0;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&=
#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#820=
4;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#=
8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160=
;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#=
160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204=
;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8204;&#160;&#8=
204;&#160;&#8204; </div><table role=3D"none" width=3D"100%" border=3D"0" ce=
llspacing=3D"0" align=3D"center" cellpadding=3D"0" class=3D"gg"><tr><td ali=
gn=3D"center" valign=3D"top"><table role=3D"none" width=3D"670" border=3D"0=
" cellspacing=3D"0" cellpadding=3D"0" class=3D"aa" style=3D"width:670px;tab=
le-layout:fixed;"><tr><td class=3D"bodyWrapper" align=3D"center" valign=3D"=
top" style=3D"padding:10px 5px 10px 5px;"><table role=3D"none" width=3D"100=
%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><t=
d align=3D"center" valign=3D"top" style=3D"border-width:0px 0px 0px 0px;bor=
der-style: solid; border-color: #FFFFFF;border-radius:10px 10px 0px 0px;bac=
kground-color:#FFFFFF;" class=3D"c"><table role=3D"none" width=3D"100%" bor=
der=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr id=3D"he=
ader"><td style=3D"padding:15px 15px 0px 15px;"><div style=3D"padding-top:0=
px;padding-right:0px;padding-bottom:20px;padding-left:0px;"><table role=3D"=
none" width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=
=3D"center"><tr><td class=3D"f" align=3D"right" valign=3D"top"><p> May 05, =
2026 &nbsp; | &nbsp; <a data-read-online-tooltip=3D"true" href=3D"https://l=
ink.mail.beehiiv.com/v1/c/Jo%2Fm4RqXhYP7f3RzIsoqtfglEB2iVzNVsof%2FT%2BPeeN7=
chGRT%2BgczoAyAwkIG%0AyTHtTvnOio%2BFaoTg4eK3nPkcfi1S%2BJ9HDoyRndjcYC8T48%2B=
YE9wL8dj8IqFI%0AXWVoMYKVDU57cwKricRKoHfkLvWEwxBC7dnbf%2FyyPmgFpLDVQozEgbpFo=
hnN%0Ami%2FCl7nja5fbENQIsVFPLyDcX56HWUFpqQ%3D%3D%0A/8e659f3507616120">Read =
online</a></p></td></tr><tr><td class=3D"dd" align=3D"center" valign=3D"top=
" style=3D"padding:15px 0;"><table role=3D"none" width=3D"100%" border=3D"0=
" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=3D"cen=
ter" valign=3D"top"><h1 style=3D"text-align:left;font-family:'Trebuchet MS'=
,'Lucida Grande',Tahoma,sans-serif;font-weight:Bold;font-size:32px;color:#2=
A2A2A;padding:2px 0;line-height:38px;"> Non-GLP Fat Loss Compounds Ranked <=
/h1><p style=3D"text-align:left;font-family:'Helvetica',Arial,sans-serif;fo=
nt-weight:normal;font-size:20px;color:#3E3E3E;padding:5px 0;line-height:24p=
x;"> New Video is Live! </p></td></tr></table></td></tr><tr><td align=3D"ce=
nter" valign=3D"top" class=3D"dd"><table role=3D"none" width=3D"100%" borde=
r=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td align=
=3D"left" valign=3D"middle" class=3D"mob-stack"><table role=3D"none" border=
=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"right" class=3D"social-=
mobile"><tr><td align=3D"left" valign=3D"middle"><table role=3D"none" borde=
r=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"left" style=3D"width:1=
00%"><tr><td align=3D"center" valign=3D"middle"><a href=3D"https://link.mai=
l.beehiiv.com/v1/c/TIhTHCthmBQW5hYMBlbP7E2y%2F0AdzlV4y9svxWQrld4h5s9JfXHEX5=
NZZ4Y7%0Ag%2B9WCmEqi4UqTFFQZZuQFc9Hy6I9Ca2gKVW3MV32PpV%2FdcYlvdSBgVaV1XWH%0=
ASLU1iyOPSkwMOZOsVWlPUnoduyDOFVznqjVgUWHT3e5LoTQJVXXSV8gDFfgQ%0A9cN%2FYJecr=
CKvSGucAcTbVs2kyl0zJi3beg%3D%3D%0A/9890dfc2876c3fcb" style=3D"text-decorati=
on:none; display:block;"><table role=3D"none" border=3D"0" cellspacing=3D"0=
" cellpadding=3D"0" align=3D"center"><tr><td align=3D"center" valign=3D"mid=
dle" style=3D"border: 1px solid #E5E7EB; border-radius: 100%; width: 18px; =
height: 18px; padding: 8px;"><img style=3D"display:block; width:100%; heigh=
t:100%; max-width:18px; max-height:18px; object-fit: contain;" alt=3D"share=
 on facebook" width=3D"18" border=3D"0" src=3D"https://media.beehiiv.com/cd=
n-cgi/image/fit=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/=
static_assets/header/facebook.png"/></td></tr></table></a></td><td width=3D=
"8" style=3D"width:8px;">&nbsp;</td><td align=3D"center" valign=3D"middle">=
<a href=3D"https://link.mail.beehiiv.com/v1/c/rGymUmEy%2BABU6P41DvRwjgxhh5D=
ZOh1YiwflHhnyJhAosTxH2rf%2F49HFyoZV%0AtjH%2BFQM6Yqr8RuUeV4IBCOfLPVuEAJjcs%2=
Fqi0g1BJGMYO6TIlOG1EVJqrky9%0AK%2FRm29%2BcdYtEbRGtevSuw95PdxKPCh1x8z8F9F0UF=
qPokEKDaW5KSoreLOuW%0AIr6WCHBbORpkO4kDRSrH%2F4RvNnHbgY21mQ%3D%3D%0A/9339047=
50430d460" style=3D"text-decoration:none; display:block;"><table role=3D"no=
ne" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><=
td align=3D"center" valign=3D"middle" style=3D"border: 1px solid #E5E7EB; b=
order-radius: 100%; width: 18px; height: 18px; padding: 8px;"><img style=3D=
"display:block; width:100%; height:100%; max-width:18px; max-height:18px; o=
bject-fit: contain;" alt=3D"share on twitter" width=3D"18" height=3D"18" bo=
rder=3D"0" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down,=
format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/header/x.png"/>=
</td></tr></table></a></td><td width=3D"8" style=3D"width:8px;">&nbsp;</td>=
<td align=3D"center" valign=3D"middle"><a href=3D"https://link.mail.beehiiv=
.com/v1/c/eI09cL0a31kbxHRfGt22weRkObuKxZe9pgIKxQaCotXcsEI8v%2FS07KGiiTyp%0A=
osDTbsM7ixc3n7%2FsCjyoejTHehBV%2BDCro5jogSJPDLQA0FULimAFvTNlsnud%0A9qBWftte=
CjLuIDis8TkAF23PBwuc3HeyzSs0cPvYaweZst972DxOzyJYKpfo%0ADRFhnjytqhgB%2F%2BHp=
jc5FKNNOFkSi7Jzrvg%3D%3D%0A/4038066c86d0e723" style=3D"text-decoration:none=
; display:block;"><table role=3D"none" border=3D"0" cellspacing=3D"0" cellp=
adding=3D"0" align=3D"center"><tr><td align=3D"center" valign=3D"middle" st=
yle=3D"border: 1px solid #E5E7EB; border-radius: 100%; width: 18px; height:=
 18px; padding: 8px;"><img style=3D"display:block; width:100%; height:100%;=
 max-width:18px; max-height:18px; object-fit: contain;" alt=3D"share on thr=
eads" width=3D"18" height=3D"18" border=3D"0" src=3D"https://media.beehiiv.=
com/cdn-cgi/image/fit=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=
=3D80/static_assets/header/threads.png"/></td></tr></table></a></td><td wid=
th=3D"8" style=3D"width:8px;">&nbsp;</td><td align=3D"center" valign=3D"mid=
dle"><a href=3D"https://link.mail.beehiiv.com/v1/c/opsahG7axIXxqTzTfH1dsTQL=
Yute6sgtN0Sg8fKRifmtu2CZ6oRgR8atnU6z%0AeK7SrKsmxaL8f1TMRWtE4f7wwAj0zOefdIxT=
gQqggx6XQ%2BEM5VTW%2BFikORfe%0A9r7YWBaWf2YZ6EGA1uDb3FRNA61m28xGzfOpW7s%2Flc=
LK1hVZSHIfX8HAKN2n%0A0V1qdqNgZVLfP7tlbA5XTP9aKpC%2BeCje%2FQ%3D%3D%0A/4aac1c=
6ceb19db6c" style=3D"text-decoration:none; display:block;"><table role=3D"n=
one" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr>=
<td align=3D"center" valign=3D"middle" style=3D"border: 1px solid #E5E7EB; =
border-radius: 100%; width: 18px; height: 18px; padding: 8px;"><img style=
=3D"display:block; width:100%; height:100%; max-width:18px; max-height:18px=
; object-fit: contain;" alt=3D"share on linkedin" width=3D"18" height=3D"18=
" border=3D"0" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-d=
own,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/header/link=
edin.png"/></td></tr></table></a></td></tr></table></td></tr></table></td><=
/tr></table></td></tr><tr><td style=3D"line-height:0;"><div data-open-track=
ing=3D"true"><img src=3D"https://link.mail.beehiiv.com/v1/o/Us%2BaCKeCHIMv%=
2BKLB%2Bb5uiE7w6dimVbTuKEEAy1HwaiCQGZDQxrQJ66uOJdV9%0As%2F%2BZAJSJYxfU0%2Fs=
8mGPlE2FGyc8lmvpDCEkKDj1TCYv51n2jQs0kyFlc1Mja%0AvF1MKEqspCq5YjxbrFglc9BAvgE=
gS%2FGukMOqEO4FP%2Fi3yQSIDjMym%2FZxXde6%0Aj0MN9MIxOY%2FNTmTedYm0J8%2BEDM9Wq=
SCCQ10GTAbdGjaCJnQp%2Bnz71VloGfJd%0AmG8TrqHUIoMao0pBP2%2B02%2B%2FPi9%2ByCmm=
V2HebSzcIuOsOP7fqy9aHQCJjuSD8%0AaFx6WR6RLg6nkzQ3YymMmiJqhVNQjLN3uJNuEYaQq32=
aZ6vu7nc91%2BWmBS9L%0AC9%2BBh43caWdrX5VyYtwbDNA76%2FGlrU0AToqPzlSbLd%2Bq3pW=
ce49Mah44RVI5%0A%2Bo6fsVvKSR6powRrNmCrFkIXlGVcoTv416uUvKugCnd%2BduHW3Q%3D%3=
D%0A/a4a2f3669b635d28.gif" alt=3D"" width=3D"1" height=3D"1" style=3D"displ=
ay:block;border:0;outline:0;"></div></td></tr></table></div></td></tr><tr i=
d=3D"content-blocks"><td class=3D"email-card-body" align=3D"center" valign=
=3D"top" style=3D"padding-bottom:px;"><table role=3D"none" width=3D"100%" b=
order=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td cl=
ass=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-br=
eak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fo=
nt-size:1.5rem;">Happy Tuesday! </span></p></td></tr><tr><td class=3D"dd" a=
lign=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-wo=
rd;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5r=
em;">Most folks would agree that the GLPs are the kings of fat loss, with r=
etatrutide holding the title belt.</span></p></td></tr><tr><td class=3D"dd"=
 align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-=
word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.=
5rem;">But what if GLPs are not on the table for you? What if you are cycli=
ng off? What if you want to stack other compounds so you don=E2=80=99t have=
 to crank your GLP dose into the stratosphere?</span></p></td></tr><tr><td =
class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-=
break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"=
font-size:1.5rem;">I just dropped a </span><span style=3D"font-size:1.5rem;=
">brand-new video and podcast episode where I rank=C2=A0</span><span style=
=3D"font-size:1.5rem;"><b>20 non-GLP-1 fat-loss</b></span><span style=3D"fo=
nt-size:1.5rem;"><b> compounds</b></span><span style=3D"font-size:1.5rem;">=
 from F tier to S tier. Most are peptides. A few are small molecules. All o=
f them have a place in the conversation right now.</span></p></td></tr><tr>=
<td class=3D"dd" align=3D"center" valign=3D"top" style=3D"padding:20px;"><a=
 href=3D"https://link.mail.beehiiv.com/v1/c/AIqiTVd0CY%2BKBP1NVAMldtQJv3Oel=
omGaoBT9Y6W9gk4uYnUL98VJ4SxOwY8%0Am6VQZ6fG89xwR87VEX3NNhvve6T41KNf7iJbzlFk3=
8TYYYUg72etjAbyxFno%0AT2MBCOQfmOPfTsviJfsbeZh19wQ8QAY8RLAzKqGpBpxwe%2FEhBwq=
xamy7JAo1%0ATtrzaJTYPBCBRNqHT%2B%2Bj0Ue5cIGtKeulDA%3D%3D%0A/0ebc324fc08960f=
7" style=3D"text-decoration:none;"><table align=3D"center" width=3D"100%" c=
ellpadding=3D"0" cellspacing=3D"0" border=3D"0" role=3D"none" style=3D"max-=
width:520px;margin:0 auto;"><tr><td class=3D"p" width=3D"100%" style=3D"pad=
ding:2px;border:none;"><table width=3D"100%" cellpadding=3D"0" cellspacing=
=3D"0" border=3D"0" role=3D"none"><tr><td align=3D"center" valign=3D"top" s=
tyle=3D"width:100%;"><div style=3D"max-height:0;position:relative;opacity:0=
.999;width:100%;mso-hide:all;"><div style=3D"display:inline-block;width:100=
%;padding-top:25%;"><img width=3D"20%" height=3D"auto" loading=3D"lazy" alt=
=3D"" style=3D"border:0;" src=3D"https://media.beehiiv.com/cdn-cgi/image/fi=
t=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/=
youtube_play_icon.png"/></div></div><a href=3D"https://link.mail.beehiiv.co=
m/v1/c/yf2GkjuWVeDB15otldHNt7qXwtyYLlGpCoodf0S8W2Lhxojixicy86fqPpvx%0AAiyzM=
ei%2BKXIjFFS2eTLoyRsz7GZ7xPvsGzMcGxWOhIkIAMWdR%2B%2Fx4knUZOn8%0AhlLWtpQeZ97=
UV03eYdHC8x0MH8tuxAlKlWG9V8QCFolCahRV6Pj65OnOa7RL%0AhlIt4r%2FujnjjgHlggviMp=
tbpQhgRF%2Bk37Q%3D%3D%0A/0a12ea0c351b0fd5" style=3D"text-decoration:none;">=
<img src=3D"https://i.ytimg.com/vi/36E7xjuFVXc/maxresdefault.jpg" width=3D"=
480" height=3D"auto" loading=3D"lazy" alt=3D"YouTube video by The Hunter Wi=
lliams Podcast" style=3D"display:block;height:auto;border:0;outline:none;te=
xt-decoration:none;background-color:#000000;width:100%;"/></a></td></tr><tr=
><td><p style=3D"font-size:12px;font-weight:500;font-style:italic;font-fami=
ly:Helvetica, Calibri, sans-serif;color: #686a6d; padding-top:0 !important;=
padding-bottom:6px !important; padding-left:4px !important;"> 20 Fat Loss C=
ompounds Ranked Worst to Best (No GLP-1s) </p></td></tr></table></td></tr><=
/table></a></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0=
px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height=
-alt:150.0%;"><span style=3D"font-size:1.5rem;">You can watch the full vide=
o here: </span><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"=
https://link.mail.beehiiv.com/v1/c/qFhyB5zUlwQqe6lE3kgjbe%2BSEfAuDwm0ixNzL%=
2BUXgP6IXjBF2eEZWZzvp1My%0A7MtV8rbuo8R6ThopcD%2FBBWaWEhYCb7adh8zdV1waGqcSoJ=
93w%2BALn4Li%2F%2BN3%0AHdip0LbODmRP%2Fxfctq%2F6WbrbDI9WfI%2F6jHwaIImyW8IW7s=
EfC7IqXgq%2FKt5H%0A%2Fr9PJe1qzSwnErei1In04jhJbYWMXOiUlg%3D%3D%0A/32c617b6da=
c43fc0" target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>https:=
//youtu.be/36E7xjuFVXc</span></a></span></p></td></tr><tr><td class=3D"dd" =
align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-w=
ord;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5=
rem;">Or listen on Spotify here: </span><span style=3D"font-size:1.5rem;"><=
a class=3D"link" href=3D"https://link.mail.beehiiv.com/v1/c/IJDcIzJYSxXX9hf=
1JKoXTaGzgH0sxWXeyvLNPxEtaRFXA5R%2B99bjTkxXMeXi%0AIB72SrRpeCGSMlOQAiS%2BKqn=
FgfTrZCU1TyVFnftGyYHqqBHdwqIQhvC7vGU3%0AJSQV9%2F5hUYnUCxDaJ9fKkMobqdO7xcWP%=
2FITUoDuqqmX4JXFPifktkrtIvjwv%0A2%2Bf2Pv1DWg1%2FVJubJJlN%2F6QENo19QfnutQ%3D=
%3D%0A/9922e31d3b19c1d9" target=3D"_blank" rel=3D"noopener noreferrer nofol=
low"><span>https://open.spotify.com/episode/3jOsxcgx8n4EaOhhaNCuCv?si=3DTIs=
_SV5eT6KTmarCWf7cZA</span></a></span></p></td></tr><tr><td class=3D"dd" ali=
gn=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word=
;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem=
;">Below is the breakdown of every compound and why I ranked it where I did=
.</span></p></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"font=
-size:0px;line-height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=
=3D"j" role=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpaddi=
ng=3D"0" align=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><=
td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo=
rd-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=
=3D"font-size:1.5rem;"><span style=3D"text-decoration:underline;"><b>F Tier=
 (I Don&#39;t Use These)</b></span></span></p></td></tr><tr><td class=3D"dd=
" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break=
-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1=
.5rem;"><b>Adipotide (FTPP).</b></span><span style=3D"font-size:1.5rem;"> T=
his one targets fat cells by killing the blood vessels that feed them. Soun=
ds elegant on paper. The problem is that the kidneys are damaged at the sam=
e doses that produce the fat loss. Phase 1 data in obese prostate cancer pa=
tients showed real fat loss but also dose-dependent renal toxicity. The ris=
k-to-reward is not there for me. I am sure people are using it. I just choo=
se not to.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D=
"padding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-l=
ine-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>HGH Fragment 1=
76-191.</b></span><span style=3D"font-size:1.5rem;"> This is not HGH. It is=
 a fragment of the HGH amino acid sequence. The human data is weak. AOD9604=
 is essentially the same thing with an added tyrosine for stability, and ev=
en AOD isn=E2=80=99t great. If you are taking HGH frag, you are wasting you=
r money.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"p=
adding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-lin=
e-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><span style=3D"text=
-decoration:underline;"><b>D Tier (Weak Use Case)</b></span></span></p></td=
></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-al=
ign:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><=
span style=3D"font-size:1.5rem;"><b>AOD9604.</b></span><span style=3D"font-=
size:1.5rem;"> A 12-week phase 2 trial showed about 2 kg of fat loss compar=
ed with placebo. That is roughly 4 to 5 pounds. Not nothing. But not exciti=
ng either when GLPs exist. I have used it. The one place it might earn its =
keep is helping with water retention from growth hormone or GH peptides. As=
 a standalone fat loss tool, skip it.</span></p></td></tr><tr><td class=3D"=
dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:bre=
ak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size=
:1.5rem;"><span style=3D"text-decoration:underline;"><b>C Tier (Use Case Ex=
ists, But Outclassed)</b></span></span></p></td></tr><tr><td class=3D"dd" a=
lign=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-wo=
rd;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5r=
em;"><b>Sermorelin.</b></span><span style=3D"font-size:1.5rem;"> It is a GH=
RH peptide. It works. It is just the weakest of the GH peptide family and h=
as been outclassed by tesamorelin, CJC, and ipamorelin. If it is what you h=
ave, fine. If you are choosing fresh, pick something else.</span></p></td><=
/tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-alig=
n:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><sp=
an style=3D"font-size:1.5rem;"><b>Setmelanotide.</b></span><span style=3D"f=
ont-size:1.5rem;"> An MC4R agonist that absolutely will suppress your appet=
ite. The problem is the nausea. I took 250 micrograms and felt fine for abo=
ut 6 hours. Then the nausea hit and lasted a day or two. Take the worst sem=
aglutide nausea you have ever felt and crank it up. The FDA-approved dose i=
s 2 to 3 mg daily, and I have no idea how anyone tolerates that. For people=
 with specific genetic obesity syndromes, it can be life-changing. For ever=
yone else, it is a glutton-for-punishment compound.</span></p></td></tr><tr=
><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;=
word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span styl=
e=3D"font-size:1.5rem;"><span style=3D"text-decoration:underline;"><b>B Tie=
r (Solid, Conditional Wins)</b></span></span></p></td></tr><tr><td class=3D=
"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:br=
eak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-siz=
e:1.5rem;"><b>Tesofensine.</b></span><span style=3D"font-size:1.5rem;"> A t=
riple monoamine reuptake inhibitor. Phase 3 data in obese Mexican patients =
showed 8.6 kg of weight loss vs 1.9 kg placebo over 24 weeks. I love this o=
ne for the cognitive lift. It feels like a nootropic. About 70% of people d=
o well on it. About 20% do terribly with insomnia, anxiety, or feeling wire=
d. I run 250 mcg and get great benefits. Watch your heart rate and blood pr=
essure.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"pa=
dding:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line=
-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>SS-31.</b></span>=
<span style=3D"font-size:1.5rem;"> Not a fat loss peptide on paper. But it =
repairs the mitochondrial hardware. Fix the mitochondria, and everything wo=
rks better, including fat loss. I run 1 to 2 mg for general optimization an=
d 5 to 10 mg for a real metabolic effect. It earns its place because it imp=
roves the rest of your stack.</span></p></td></tr><tr><td class=3D"dd" alig=
n=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;=
"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;=
"><b>Cagrilintide.</b></span><span style=3D"font-size:1.5rem;"> A long-acti=
ng amylin analog that suppresses appetite through a completely different me=
chanism than GLPs. With semaglutide, it produced 20.4% weight loss over 68 =
weeks. On its own, around 10 to 11% at higher doses. I do great on it. My w=
ife, Taylor, feels depressed and emotionally blunted on it. About half the =
people I see using it report that. Coin flip. Start at 250 mcg and titrate =
up.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddin=
g:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-hei=
ght-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>IGF-1 LR3.</b></span>=
<span style=3D"font-size:1.5rem;"> This is more of a body recomposition too=
l than a fat-loss tool. Run alongside HGH or a GH peptide for 4 to 6 weeks =
at 25 to 200 mcg post-workout. Watch your blood sugar. Always have carbs on=
 hand. Hypoglycemia is the real risk.</span></p></td></tr><tr><td class=3D"=
dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:bre=
ak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size=
:1.5rem;"><b>Cardarine (GW501516).</b></span><span style=3D"font-size:1.5re=
m;"> A PPAR agonist that shifts you toward fatty acid oxidation. By itself,=
 it will not melt fat. Paired with cardio, you get way more out of every se=
ssion. I run 10 mg per day for 4 to 8 weeks. There is a cancer signal in mi=
ce (in both directions), which is why I keep doses moderate and cycle.</spa=
n></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15=
px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:=
150.0%;"><span style=3D"font-size:1.5rem;"><span style=3D"text-decoration:u=
nderline;"><b>A Tier (Where Things Get Real)</b></span></span></p></td></tr=
><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:l=
eft;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span =
style=3D"font-size:1.5rem;"><b>CJC + Ipamorelin.</b></span><span style=3D"f=
ont-size:1.5rem;"> Not a fat loss peptide directly. But the downstream effe=
cts on sleep, IGF-1, and recovery move the needle on body composition. Most=
 people tolerate ipamorelin well. CJC can give some folks reactions. Try th=
em in isolation first before stacking. I would call this an A-minus.</span>=
</p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px=
;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt:15=
0.0%;"><span style=3D"font-size:1.5rem;"><b>MOTS-c.</b></span><span style=
=3D"font-size:1.5rem;"> A mitochondrial peptide that improves fatty acid ox=
idation, glucose uptake, and insulin sensitivity. Acts as an exercise mimet=
ic. I run 1 to 2 mg subQ daily, 5 days on, 2 days off, for 8 weeks on, 8 we=
eks off. At 1 milligram with 5-Amino, I felt like a 7-year-old being told t=
o sit still. Solid A or A+.</span></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
><b>5-Amino-1MQ.</b></span><span style=3D"font-size:1.5rem;"> An NNMT inhib=
itor that raises intracellular NAD+ and makes fat cells resistant to lipoly=
sis blockade. Mouse studies show a 30 to 40% reduction in fat cell size wit=
h no change in food intake. Injectable works much better than oral. I run 1=
 to 2 mg injected daily. Push past 2 milligrams, and you start to feel burn=
out. With MOTS-c, I would call the combo an A+.</span></p></td></tr><tr><td=
 class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word=
-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D=
"font-size:1.5rem;"><b>BAM15.</b></span><span style=3D"font-size:1.5rem;"> =
A mitochondrial uncoupler. Your cell burns more fuel to maintain ATP, and t=
he energy gets dumped as heat. Wider therapeutic window than DNP. Strong ro=
dent data, no human safety pharmacology yet. I run 50 to 100 mg a day. Abov=
e 400 mg, there are diminishing returns.</span></p></td></tr><tr><td class=
=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break=
:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-=
size:1.5rem;"><b>SLU-PP-332.</b></span><span style=3D"font-size:1.5rem;"> A=
n estrogen-related receptor agonist that drives mitochondrial biogenesis an=
d fatty acid oxidation. The most studied exercise mimetic in this class. I =
prefer 250-750 mcg daily for 8-12 weeks. Higher doses just made me feel wor=
se. Oral works fine. Transdermal works great. Injectable in oil might be th=
e best delivery method, but the data isn&#39;t clean enough yet to call it.=
</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0=
px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height=
-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>ATX-304.</b></span><span=
 style=3D"font-size:1.5rem;"> A pan-AMPK activator that does not cross the =
blood-brain barrier. Real human data, no appetite suppression, no muscle lo=
ss. Trials used 1,000 milligrams, which is cost-prohibitive for most. I get=
 great results at 300-500 mg daily. Energy is solid, fat loss is real, and =
water retention drops. A+.</span></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
><b>Mirabegron.</b></span><span style=3D"font-size:1.5rem;"> A beta-3 adren=
ergic agonist. Activates brown fat thermogenesis and improves insulin sensi=
tivity. FDA-approved for overactive bladder. For body comp, 50-100 mg a day=
. Great for the last few weeks of a cut. Watch your heart rate, blood press=
ure, and urinary retention at higher doses.</span></p></td></tr><tr><td cla=
ss=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-bre=
ak:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"fon=
t-size:1.5rem;"><span style=3D"text-decoration:underline;"><b>S Tier (The B=
est We Have)</b></span></span></p></td></tr><tr><td class=3D"dd" align=3D"l=
eft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p s=
tyle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"><b>A=
lbuterol.</b></span><span style=3D"font-size:1.5rem;"> A beta-2 agonist tha=
t activates lipolysis through hormone-sensitive lipase. Increases resting e=
nergy expenditure 3 to 5%. FDA-approved since 1981 with decades of safety d=
ata. I run 2 to 5 mg orally per day, 2 weeks on 2 weeks off. The receptors =
downregulate after about 2 to 3 weeks, which is why you cycle. The only rea=
son I call it S-minus is that short cycle window. </span></p></td></tr><tr>=
<td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;w=
ord-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=
=3D"font-size:1.5rem;"><b>HGH.</b></span><span style=3D"font-size:1.5rem;">=
 The most underrated fat loss tool we have. Direct GH receptor activation. =
Increased fatty acid oxidation. Reduced glucose uptake in fat tissue. Decad=
es of human data. In GH-deficient adults, 4 to 7 kg fat reduction and 2 to =
5 kg lean mass increase over 6 to 12 months. Most men in their 40s, 50s, an=
d 60s probably qualify as deficient. Run 1 to 4 IU daily. It is not a 2-wee=
k shred tool. Over 1 to 2 years, the body just transforms.</span></p></td><=
/tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-alig=
n:left;word-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><sp=
an style=3D"font-size:1.5rem;"><b>Tesamorelin.</b></span><span style=3D"fon=
t-size:1.5rem;"> S-tier-plus from a data standpoint. A GHRH that stimulates=
 pulsatile pituitary GH release. Phase 3 data in HIV lipodystrophy patients=
 showed about 15% reduction in visceral fat over 6 months, with lean mass p=
reserved or increased. The only non-GLP-1 fat loss peptide with phase 3 hum=
an data and FDA approval. 1 to 2 mg subQ daily, 5 days on 2 days off, 8 to =
16 weeks on, 4 to 8 weeks off. If you are already lean and chasing single-d=
igit body fat, the water retention may mask the changes. If you are 25%+ bo=
dy fat trying to drop into the teens, this works incredibly well.</span></p=
></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"font-size:0px;l=
ine-height:0px;padding:30px 0px 30px;" class=3D"dd"><table class=3D"j" role=
=3D"none" width=3D"50%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" al=
ign=3D"center"><tr><td> &nbsp; </td></tr></table></td></tr><tr><td class=3D=
"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:br=
eak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-siz=
e:1.5rem;"><b>Final Thoughts</b></span></p></td></tr><tr><td class=3D"dd" a=
lign=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-wo=
rd;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5r=
em;">Every compound on this list has a place. Even the F-tier ones have a u=
se case for somebody, just not for me.</span></p></td></tr><tr><td class=3D=
"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:br=
eak-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-siz=
e:1.5rem;">The mistake people make is reaching for one tool and cranking th=
e dose until something gives. With everything on this list, you can rotate =
through different mechanisms. </span></p></td></tr><tr><td class=3D"dd" ali=
gn=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word=
;"><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem=
;">AMPK one cycle. Mitochondrial uncoupling the next. Brown fat thermogenes=
is the cycle after that. Each pathway hits differently. Each cycle gives th=
e others a chance to reset.</span></p></td></tr><tr><td class=3D"dd" align=
=3D"left" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"=
><p style=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;"=
>Hormones first. Lifestyle second. Compounds third. That order does not cha=
nge.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddi=
ng:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-he=
ight-alt:150.0%;"><span style=3D"font-size:1.5rem;">Also, remember this is =
just my opinion. There are great compounds I left off this list. There are =
people smarter than me who would rank some of these differently. I would ac=
tually love to hear it. If you think I got something wrong, drop it in the =
YouTube or Spotify comments. The conversation is what moves the field forwa=
rd.</span></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"paddin=
g:0px 15px;text-align:left;word-break:break-word;"><p style=3D"mso-line-hei=
ght-alt:150.0%;"><span style=3D"font-size:1.5rem;">If you want my full reas=
oning on each compound, the dosing protocols, and the reactions I have pers=
onally seen, watch the video or listen to the episode. I cover way more tha=
n I could fit in here.</span></p></td></tr><tr><td class=3D"dd" align=3D"le=
ft" style=3D"padding:0px 15px;text-align:left;word-break:break-word;"><p st=
yle=3D"mso-line-height-alt:150.0%;"><span style=3D"font-size:1.5rem;">As al=
ways, thank you for being here. I have the best audience in the world! </sp=
an></p></td></tr><tr><td class=3D"dd" align=3D"left" style=3D"padding:0px 1=
5px;text-align:left;word-break:break-word;"><p style=3D"mso-line-height-alt=
:150.0%;"><span style=3D"font-size:1.5rem;">Best,</span></p></td></tr><tr><=
td class=3D"dd" align=3D"left" style=3D"padding:0px 15px;text-align:left;wo=
rd-break:break-word;"><p style=3D"mso-line-height-alt:150.0%;"><span style=
=3D"font-size:1.5rem;">Hunter Williams</span></p></td></tr></table></td></t=
r></table></td></tr><tr><td align=3D"center" valign=3D"top"><table role=3D"=
none" width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=
=3D"center"><tr><td><tr><td class=3D"b" align=3D"center" valign=3D"top" bgc=
olor=3D"#FFFFFF" style=3D"padding:0px 0px 0px 0px;border-style:solid;border=
-width: 0px 0px 0px 0px;border-color: #FFFFFF;border-bottom-left-radius:10p=
x;border-bottom-right-radius:10px;"><table role=3D"none" width=3D"100%" bor=
der=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td alig=
n=3D"center" valign=3D"top" bgcolor=3D"#030712" style=3D"padding:12px"><tab=
le role=3D"none" width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" align=3D"center"><tr><td><span style=3D"padding-left:1px;"></span></=
td><td align=3D"center" valign=3D"middle" width=3D"75" style=3D"width:75px;=
"><a href=3D"https://link.mail.beehiiv.com/v1/c/B7ZFH3n7008OtW5L6hqjoRQ2p3e=
uER9LU1PIO%2BHIavQtxZTrL5SSxiemvISq%0ATZGfE9YdfbOqhTZbMmsdxdvypAiaGmWUPOEqh=
%2BtlB4GY1t4g%2B4Z8C%2FTQS82U%0AMAvITcpqkHk6VO%2BN3%2BQ2Uo7rITnHoeuZ3rG%2F2=
qcT%2B7QVjuT0im%2BjmvQ%2F8s1R%0Ak7kSnWXrXbMFtGvB2mxpHD39%2Fbj8ureJ9A%3D%3D%=
0A/eb794cc952a96a13" style=3D"text-decoration:none;"><img width=3D"22" heig=
ht=3D"22" alt=3D"ig" border=3D"0" style=3D"display:block;max-width:22px;col=
or:light" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down,f=
ormat=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/instagram_light.=
png"/></a></td><td align=3D"center" valign=3D"middle" width=3D"75" style=3D=
"width:75px;"><a href=3D"https://link.mail.beehiiv.com/v1/c/eIXNELqlTc5xHp4=
zKys2VlJJpPNMT9VYAVHimvTBrO%2BiZB4cItphoQbN%2FxW1%0AZ27wXOinhNNSflAWDRP2x0n=
%2Fj5Kcd641tBYBBtAhnmxttUbErVk%2FJ2giNea%2B%0Atx1hyV2YtUCSGK6kRsZfUAvNNkx1Q=
h7dQpKmd68V0C2wld2KlhWgcvr6icvp%0AGSGRGLlhaHTILKqIVJO2WACpRAh%2FEzo4wA%3D%3=
D%0A/59edac30d18ca701" style=3D"text-decoration:none;"><img width=3D"22" he=
ight=3D"16" alt=3D"yt" border=3D"0" style=3D"display:block;max-width:22px;c=
olor:light" src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=3Dscale-down=
,format=3Dauto,onerror=3Dredirect,quality=3D80/static_assets/youtube_light.=
png"/></a></td><td><span style=3D"padding-left:1px;"></span></td></tr></tab=
le></td></tr><tr><td align=3D"center" valign=3D"top" style=3D"padding-botto=
m:20px;padding-left:15px;padding-right:15px;padding-top:20px; " class=3D"dd=
"><table role=3D"none" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" sty=
le=3D"margin:0 auto 0 auto;"><tr><td align=3D"center" valign=3D"top" style=
=3D"width:189px;"><img src=3D"https://media.beehiiv.com/cdn-cgi/image/fit=
=3Dscale-down,format=3Dauto,onerror=3Dredirect,quality=3D80/uploads/asset/f=
ile/77285135-fcd3-48e6-afed-97045dbefd05/beehiiv_profile_photo_large.png?t=
=3D1744125569" alt=3D"" height=3D"auto" width=3D"189" style=3D"display:bloc=
k;width:100%;border-radius:0px 0px 0px 0px;border-style:solid;border-width:=
0px 0px 0px 0px;box-sizing:border-box;border-color:#E5E7EB;" border=3D"0"/>=
</td></tr></table></td></tr><tr><td id=3D"want-more-heres-how-you-can-work-=
wi" class=3D"dd" align=3D"center" valign=3D"top" style=3D"color:#2A2A2A;fon=
t-weight:normal;padding:0px 15px;text-align:center;"><h2 style=3D"color:#2A=
2A2A;font-weight:normal;mso-line-height-alt:150.0%;"><span style=3D"font-si=
ze:1.5rem;">Want more? Here=E2=80=99s how you can work with me:</span></h2>=
</td></tr><tr><td id=3D"join-my-private-coaching-group-the-" class=3D"dd" a=
lign=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:normal;padd=
ing:0px 15px;text-align:left;"><h4 style=3D"color:#2A2A2A;font-weight:norma=
l;mso-line-height-alt:112.5%;"><span style=3D"font-size:1.5rem;">=F0=9F=91=
=89Join my private coaching group, The AXION Collective:</span></h4></td></=
tr><tr><td style=3D"padding-bottom:12px;padding-left:37px;padding-right:27p=
x;padding-top:12px;" class=3D"ee"><div style=3D"margin-left:0px;" class=3D"=
edm_outlooklist"><ul style=3D"font-weight:normal;list-style-type:disc;margi=
n-bottom:12px !important;margin-top:12px !important;padding:0px 0px 0px 0px=
;"><li class=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;pad=
ding:0px;text-align:left;word-break:break-word;"><span style=3D"font-size:1=
.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com/v1/c/DAgsTs=
Irgn%2FzPP%2BbKShd%2Fzc4qeB6QIg8fJgCfKiGOJm2y6Qs4cYGxAm9l%2FtP%0Afxko5f4N7%=
2FvmuAFyPtU1zMI50W4qFGbn4%2F4ByiTDWPw9lBHIzG0uDMx%2FDJuP%0AnPK1NgS67LIBgupN=
lk2ymdEGWG5Kbpw9SjML2EW9brnERjGVoVFh245R55Pv%0ABP3QfhkVFqKLRfb2qBjHr1t5B%2B=
YZmApQ9w%3D%3D%0A/513add34f9449aca" target=3D"_blank" rel=3D"noopener noref=
errer nofollow"><span>The AXION Collective</span></a></span></p></li></ul><=
/div></td></tr><tr><td id=3D"try-zeroats-the-worlds-first-sugarf" class=3D"=
dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:normal=
;padding:0px 15px;text-align:left;"><h4 style=3D"color:#2A2A2A;font-weight:=
normal;mso-line-height-alt:112.5%;"><span style=3D"font-size:1.5rem;">=F0=
=9F=91=89Try Zeroats, the world=E2=80=99s first sugar-free, naturally flavo=
red oatmeal:</span></h4></td></tr><tr><td style=3D"padding-bottom:12px;padd=
ing-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=
=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:no=
rmal;list-style-type:disc;margin-bottom:12px !important;margin-top:12px !im=
portant;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D=
"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-wo=
rd;"><span style=3D"font-size:1.5rem;">Store:=C2=A0</span><span style=3D"fo=
nt-size:1.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com/v1=
/c/WsTN1JThwxBpJOcteAY4LCE38pAlNo7IOYIQ5d8TzdxxD7NRHdRwKqcU7vRw%0ANlaZ%2FE3=
0P8%2BHLnsv8hXdlZMUIXKoY%2FaZ057MazkhJF%2F2PrOVOSG5AW%2BLgZ8w%0Aa31vZPDhjkE=
KX2NH3oLxCXgI6sqBZj9XS%2BM%2Fr4t53gZhpG4rkd8Ms4DCS6Jp%0ATpwkqMc6n766Y2HPMru=
Yakv2lxiAf%2FHBxw%3D%3D%0A/3a97d4d0d1acd3d6" target=3D"_blank" rel=3D"noope=
ner noreferrer nofollow"><span>https://zeroats.com/</span></a></span><span =
style=3D"font-size:1.5rem;">=C2=A0</span></p></li><li class=3D"listItem ult=
ext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;wor=
d-break:break-word;"><span style=3D"font-size:1.5rem;">Amazon:=C2=A0</span>=
<span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.ma=
il.beehiiv.com/v1/c/yi0KYNaHDRnyCkOXwQ82Hn4Av9%2FiOmd2Ww3aEnOX5VPvmghMxVqLC=
OrSose5%0ANKEEYnmMRThY1U2VSbNatvJPXFSasTkCeHLQiV2tWMxGTsQN6LDnV%2B8gD%2Fn2%=
0AhNWL0duFIwKnfGL30DXFyDrXQjdWT4i4U95YfmOg5MM%2Fp4XV23P073vY9QWg%0AXJ8nxrOH=
kOVjBTIwWZnqLDBEFedhpiA2%2BQ%3D%3D%0A/7f79cc761819e2ab" target=3D"_blank" r=
el=3D"noopener noreferrer nofollow"><span>https://a.co/d/2gq1zJ9</span></a>=
</span></p></li></ul></div></td></tr><tr><td id=3D"link-to-all-my-old-video=
s" class=3D"dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-w=
eight:normal;padding:0px 15px;text-align:left;"><h4 style=3D"color:#2A2A2A;=
font-weight:normal;mso-line-height-alt:112.5%;"><span style=3D"font-size:1.=
5rem;">=F0=9F=91=89</span><span style=3D"font-size:1.5rem;">Link To All My =
Old Videos:</span></h4></td></tr><tr><td style=3D"padding-bottom:12px;paddi=
ng-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=
=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:no=
rmal;list-style-type:disc;margin-bottom:12px !important;margin-top:12px !im=
portant;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D=
"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-wo=
rd;"><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://li=
nk.mail.beehiiv.com/v1/c/IXFd9zXYtiQmHdkOyAsgPA%2FDEU7TaobjcZMM2Gnqo1N773pN=
GmOL%2F7U0QPqD%0AJ29dsiK36BdUENZ%2BWOxAvqZBMi7A7PRF%2FLOhN4puQd%2Bd57pbu5Yz=
sAC%2BUfiw%0A%2FGW%2BxqHzZGXmyzCfGrCAN06KdS%2FNQV6tobk1JVpyBPA0qKsD9c7WIo9M=
WoLK%0A%2BXkiHJyfZ0rV%2F3UyE%2FPJgh77ky1oNRjyNQ%3D%3D%0A/a76a92e924df8390" =
target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>DropBox with a=
ll videos</span></a></span></p></li></ul></div></td></tr><tr><td id=3D"link=
-to-all-my-old-videos" class=3D"dd" align=3D"left" valign=3D"top" style=3D"=
color:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h4 sty=
le=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:112.5%;"><span s=
tyle=3D"font-size:1.5rem;">=F0=9F=91=89</span><span style=3D"font-size:1.5r=
em;">Audio Versions of All Videos:</span></h4></td></tr><tr><td style=3D"pa=
dding-bottom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" c=
lass=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul s=
tyle=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !importa=
nt;margin-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listIt=
em ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:le=
ft;word-break:break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"li=
nk" href=3D"https://link.mail.beehiiv.com/v1/c/6uTz5NPHN6mcCoInRhzc6L9l%2BE=
MR7jkZiNwQsRHd6H4FOpSI9R33qgpuklZT%0AsbvqboqHTpSgAu9bik9Zp7wje0ThahD5s4ojwh=
7KTKVlswylB%2BTrr9iANHVP%0APyvJgfUhUXauW%2Bbtqbbr55AWFxCPO2E8rMgdexaGA%2Bkb=
L%2BSD1eGfZMozaOLp%0A8WJpP33UhJUMW3U%2FniqvH5CrnDDzSTpINA%3D%3D%0A/099415f9=
fa03a146" target=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>Itun=
es</span></a></span></p></li><li class=3D"listItem ultext"><p style=3D"mso-=
line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-word;">=
<span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.ma=
il.beehiiv.com/v1/c/%2BiJOnNID5dfd%2Bk6ZDdOq9Cam2u8aDNz0gBYX7hkRCkLISYemkmX=
lE4IG51DN%0AJfSiZkb9oMt47znwPKycxz3AUPdjvlWr6z%2Bzv3mLAxf3IhfZtbJiX0WJF0Ie%=
0A5HRvQy%2FEEZtZRK6saDTyvAizky5W4v86cp9cpu9YG9xmdA6YElO9vyPy1Xzs%0Atbkr8EDr=
ZIE2liJ1%2BJEz9I5I2lTS2byQLg%3D%3D%0A/7246b712a5231e04" target=3D"_blank" r=
el=3D"noopener noreferrer nofollow"><span>Spotify</span></a></span></p></li=
></ul></div></td></tr><tr><td id=3D"get-the-peptide-cheat-sheet" class=3D"d=
d" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:normal;=
padding:0px 15px;text-align:left;"><h3 style=3D"color:#2A2A2A;font-weight:n=
ormal;mso-line-height-alt:125.0%;"><span style=3D"font-size:1.5rem;">=F0=9F=
=91=89Get the Peptide Cheat Sheet:</span></h3></td></tr><tr><td style=3D"pa=
dding-bottom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" c=
lass=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul s=
tyle=3D"font-weight:normal;list-style-type:disc;margin-bottom:12px !importa=
nt;margin-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listIt=
em ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:le=
ft;word-break:break-word;"><span style=3D"font-size:1.5rem;"><a class=3D"li=
nk" href=3D"https://link.mail.beehiiv.com/v1/c/yj4yONgXp5gJihs6CX4%2BgsVktd=
jlsZYJWgnhe%2BFqWZTy1RI%2Bb%2FiaYfS%2FtNZk%0A1%2Fe7OSDHj4dJ3E%2FpGkj%2BlNxQ=
5y0eS48mFTqmxo55ezHdfruYy4L5Q7NAjshr%0A7ThHcPgXHLILR7zgf56ryKvA0ILxSSPf8drm=
L7S1y3bX3AUFacHLp8hwwQs%2B%0AlValbwE%2FAmUtyoR6nMZ5zKYgPQibEvP8qQ%3D%3D%0A/=
e84a076806999634" target=3D"_blank" rel=3D"noopener noreferrer nofollow"><s=
pan>Peptide Cheat Sheet</span></a></span></p></li></ul></div></td></tr><tr>=
<td id=3D"all-my-daily-essentials-on-amazon" class=3D"dd" align=3D"left" va=
lign=3D"top" style=3D"color:#2A2A2A;font-weight:normal;padding:0px 15px;tex=
t-align:left;"><h3 style=3D"color:#2A2A2A;font-weight:normal;mso-line-heigh=
t-alt:125.0%;"><span style=3D"font-size:1.5rem;">=F0=9F=91=89All my daily e=
ssentials on Amazon</span></h3></td></tr><tr><td style=3D"padding-bottom:12=
px;padding-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><di=
v style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-we=
ight:normal;list-style-type:disc;margin-bottom:12px !important;margin-top:1=
2px !important;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p s=
tyle=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-break:b=
reak-word;"><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"htt=
ps://link.mail.beehiiv.com/v1/c/AsU4kADT%2B4THBF0PX8SudHo1XoTWV1X6hqDzdrROD=
MuPNZ0JylSiqhN2MqjP%0AGR2NIEnPWRxs1NXbOyNsFyS9gSLVn5PyNqdK%2BVbZLQMu4YDSJBr=
EQklRKOW2%0AD9s8j7nSs5Wh%2BGMBN2%2FI%2F6D7mTFXsT4QG1A5AK9nkXPKk6L1wGerMmlsy=
fq7%0AJFnuiF6uYRlxWE26pSdeVELLqru7z9p%2B2g%3D%3D%0A/8cf1a723a9bd1ea8" targe=
t=3D"_blank" rel=3D"noopener noreferrer nofollow"><span>Amazon Storefront</=
span></a></span></p></li></ul></div></td></tr><tr><td id=3D"get-discounts-o=
n-your-favorite-pept" class=3D"dd" align=3D"left" valign=3D"top" style=3D"c=
olor:#2A2A2A;font-weight:normal;padding:0px 15px;text-align:left;"><h3 styl=
e=3D"color:#2A2A2A;font-weight:normal;mso-line-height-alt:125.0%;"><span st=
yle=3D"font-size:1.5rem;">=F0=9F=91=89Get discounts on your favorite peptid=
es and research chemicals:</span></h3></td></tr><tr><td style=3D"padding-bo=
ttom:12px;padding-left:37px;padding-right:27px;padding-top:12px;" class=3D"=
ee"><div style=3D"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"=
font-weight:normal;list-style-type:disc;margin-bottom:12px !important;margi=
n-top:12px !important;padding:0px 0px 0px 0px;"><li class=3D"listItem ultex=
t"><p style=3D"mso-line-height-alt:150.0%;padding:0px;text-align:left;word-=
break:break-word;"><span style=3D"color:#ff0000;font-family:Verdana,Geneva,=
sans-serif;font-size:1.5rem;font-weight:700;">PEPTIDES</span></p><ul style=
=3D"list-style-type:circle;margin:0px 0px;padding:0px 0px 0px 0px;"><li cla=
ss=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;t=
ext-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;">Bi=
oLongevity Labs (use code hunterw for 15% off):=C2=A0</span><span style=3D"=
font-size:1.5rem;"><a class=3D"link" href=3D"https://link.mail.beehiiv.com/=
v1/c/xkG1%2BJqPvEpQU6JEj97yhxO1SE84jA%2Bm1gzEAzot3ScqvGv08wHFUSImrwTv%0Aw4L=
CZwx%2BeRWZeEemtFXAns7%2BCJzRrEF1YVmAXieH%2BcE%2F9aMIbJujBzg7zPk9%0AYIPV5rE=
cqZF%2FkO8CKBPqgUzNMLfXMSmWlDfkonvlCwxM0bDxvhq7s2Y35FJt%0A8YMW9F0pBXGVXyYi%=
2BZYx9AFU3KjcasFRFw%3D%3D%0A/b68b732154e2357e" target=3D"_blank" rel=3D"noo=
pener noreferrer nofollow"><span>https://biolongevitylabs.com/</span></a></=
span><span style=3D"font-size:1.5rem;">=C2=A0</span></p></li></ul></li></ul=
></div></td></tr><tr><td id=3D"10-off-my-favorite-protein-powder-a" class=
=3D"dd" align=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:no=
rmal;padding:0px 15px;text-align:left;"><h3 style=3D"color:#2A2A2A;font-wei=
ght:normal;mso-line-height-alt:125.0%;"><span style=3D"font-size:1.5rem;">=
=F0=9F=91=8910% off the BEST workout supplements from Unmatched Supps (pre-=
workout, whey protein, creatine, EAAs, electrolytes - use code HUNTERW at c=
heckout):</span></h3></td></tr><tr><td style=3D"padding-bottom:12px;padding=
-left:37px;padding-right:27px;padding-top:12px;" class=3D"ee"><div style=3D=
"margin-left:0px;" class=3D"edm_outlooklist"><ul style=3D"font-weight:norma=
l;list-style-type:disc;margin-bottom:12px !important;margin-top:12px !impor=
tant;padding:0px 0px 0px 0px;"><li class=3D"listItem ultext"><p style=3D"ms=
o-line-height-alt:150.0%;padding:0px;text-align:left;word-break:break-word;=
"><span style=3D"font-size:1.5rem;"><a class=3D"link" href=3D"https://link.=
mail.beehiiv.com/v1/c/iPndNOA0qKOG40oe9M0hE%2BXvDfoIiJFnnAIPI3XFwdaB7D%2Bas=
Jmk4Cp6mt95%0AhmF7mhtntJHsyP9pZSvSSf5nzJON3bojTFqokEPF1trMaJm%2F1xfGsEn1eQA=
c%0AMJxQRsUjBxXsnt0o2Dc7rJTGMDswP7%2BUVfWdmkGrE%2BzdGDiv5w279uk%2FqmzO%0Aec=
pUsHieYW6Ac8ejAfXzBZcUtM60DBe86A%3D%3D%0A/79ce09658aa2020d" target=3D"_blan=
k" rel=3D"noopener noreferrer nofollow"><span>https://www.unmatchedsupps.co=
m?sca_ref=3D8677061.S6mh8SOsogBzjOO</span></a></span></p></li></ul></div></=
td></tr><tr><td id=3D"submit-a-video-topic-for-my-next-yo" class=3D"dd" ali=
gn=3D"left" valign=3D"top" style=3D"color:#2A2A2A;font-weight:normal;paddin=
g:0px 15px;text-align:left;"><h3 style=3D"color:#2A2A2A;font-weight:normal;=
mso-line-height-alt:125.0%;"><span style=3D"font-size:1.5rem;">=F0=9F=91=89=
Submit A Video Topic For My Next YouTube Video:</span></h3></td></tr><tr><t=
d style=3D"padding-bottom:12px;padding-left:37px;padding-right:27px;padding=
-top:12px;" class=3D"ee"><div style=3D"margin-left:0px;" class=3D"edm_outlo=
oklist"><ul style=3D"font-weight:normal;list-style-type:disc;margin-bottom:=
12px !important;margin-top:12px !important;padding:0px 0px 0px 0px;"><li cl=
ass=3D"listItem ultext"><p style=3D"mso-line-height-alt:150.0%;padding:0px;=
text-align:left;word-break:break-word;"><span style=3D"font-size:1.5rem;"><=
a class=3D"link" href=3D"https://link.mail.beehiiv.com/v1/c/EaTgzbZu0CGieMC=
r6YnEmBJu5CyZJzZGWJJQB1O23dYzHrMNKPRNBCprdyHT%0AnsenIaQNsSJ5vGQ7vo%2FQshd8X=
sBzmQ65NOOrVIN8SQbRV%2BcOrY0xXLQ0ifn%2B%0Au0DUBbejkD7LoNyD7ifsGYmrLEVAA2IPo=
VgMFtJAsCTFc%2Fc3YCseZ0sXNquv%0AoZ0QthxPVeRlf9cYU7vn97jYyN7hT1yDiA%3D%3D%0A=
/ef8cb4f3c1e65099" target=3D"_blank" rel=3D"noopener noreferrer nofollow"><=
span>https://hunterwilliamsvideotopic.carrd.co/</span></a></span></p></li><=
/ul></div></td></tr><tr><td class=3D"w" align=3D"center" valign=3D"top" sty=
le=3D"padding:15px 15px 15px 15px;"><table role=3D"none" width=3D"100%" bor=
der=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center"><tr><td alig=
n=3D"center" valign=3D"top"><p style=3D"font-family:'Verdana',Geneva,sans-s=
erif;color:#2D2D2D!important;"> Update your email preferences or unsubscrib=
e <a class=3D"link" href=3D"https://link.mail.beehiiv.com/v1/c/sOVGvm%2Bb2Q=
0y%2B8P4iqLfM5aDYjBpUe%2B2%2FdGGSv4rwW571gSblPeIzAgBJPQ6%0AQnsveaqiomakk0Gh=
ho8k7cUn1UHShtJoApMhl5pg994i0pVEjxE7yD6SNApO%0AfcMXKbpiJqCh2%2BJMAUR4uptgqe=
lOm4159M3mt8TvD1du37iahaCeD4nYxxKa%0AAtJaT0Tov8ogNYeOzyo48uca9uzP3k7tGw%3D%=
3D%0A/8e83df32084820ae" style=3D"text-decoration:underline;text-decoration-=
color:#2D2D2D!important;color:#2D2D2D!important;"> here</a></p><p class=3D"=
copyright" style=3D"font-family:'Verdana',Geneva,sans-serif;color:#2D2D2D!i=
mportant;"> &copy; 2026 Hunter&#39;s Health Hacks </p><p style=3D"font-fami=
ly:'Verdana',Geneva,sans-serif;color:#2D2D2D!important;"> 228 Park Ave S, #=
29976, New York, New York 10003, United States </p></td></tr><tr style=3D"d=
isplay: table-row !important;"><td align=3D"center" valign=3D"top" style=3D=
"padding-top:20px;" style=3D"display:table-cell !important;"><table role=3D=
"none" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"center" st=
yle=3D"display:table !important;"><tr style=3D"display:table-row !important=
;"><td class=3D"u" align=3D"center" valign=3D"middle" height=3D"32" style=
=3D"height:32px;display:table-cell !important; max-height: 32px !important;=
margin:0px !important; background-color: #ffffff !important;"><a style=3D"l=
ine-height:32px !important;text-decoration:none;display:block !important;" =
href=3D"https://link.mail.beehiiv.com/v1/c/OqPcrnf%2BZ9hbi6UN0VyjqVLxeqJMrF=
rfgcyPP01lpPcJXxQhSCnGna97qLQY%0AixtbpdXD%2BfdzRUFoHyePjyiT9zd1KAawgrNr545Q=
e%2B%2BTdYkOc9vsz%2F9Q8%2FPT%0AzKlnAPOYQhIOuoJiClH%2FRtjFnTPUKPPbYUxQYSAvwa=
R%2FX0yX0Z1J3V42gi%2Bk%0AzhLfLr0L8eJJX2LJpXzCP3Rk%2FeQkFTyS8g%3D%3D%0A/a7ff=
6bc4aa1937d8"><img src=3D"https://media.beehiiv.com/output-onlinepngtools.p=
ng" width=3D"16" alt=3D"beehiiv logo" style=3D"display:inline-block !import=
ant;max-width:16px !important; vertical-align:-3px !important;width: 16px !=
important;" border=3D"0"/><span style=3D"padding-left:11px !important;displ=
ay: inline-block !important;">Powered by beehiiv</span></a></td></tr></tabl=
e></td></tr><tr><td align=3D"left" valign=3D"top" height=3D"2" style=3D"hei=
ght:2px;"><a href=3D'https://hp.beehiiv.com/9c40d639-6e1d-4292-a9d7-0e4cbbb=
5d5db' style=3D"color: #FFFFFF !important; cursor: default; font-size: 1px;=
 text-decoration: none;"> Terms of Service </a></td></tr><tr><td align=3D"l=
eft" valign=3D"top" height=3D"2" style=3D"height:2px;"><a href=3D'https://e=
mail.beehiivstatus.com/1e0b155c26e5b0417b5a2dfc8362ecaf9409e7bf/hclick' cli=
cktracking=3D"off" style=3D"color: #FFFFFF !important; cursor: default; fon=
t-size: 1px; text-decoration: none;"></a></td></tr></table></td></tr></tabl=
e></td></tr></td></tr></table></td></tr></table></td></tr></table></td></tr=
></table></div></body></html>
--u4HWCmXeT+aYztS0dSW/Ug--
